Conference slides

Andrew Bate - Industry perspective: post-authorisation evidence generation
2.57MB

Ane Auraaen - Using routinely collected data to inform pharmaceutical policies: report for OECD and EU countries
1.90MB

David King - Licensing routes and accelerated access to innovative medicines in an evolving regulatory landscape
1.07MB

David Thomson - NICE perspective: working in coordination with regulatory authorities and stakeholders to facilitate access to innovative medicines
1.06MB

Ian Hudson - Looking into the future – role of the regulator as part of the global innovation ecosystem 
2.72MB

Lorraine Nolan - Looking into the future – role of the regulator as part of the global innovation ecosystem 
2.11MB

Martyn Ward - MHRA perspective: looking forward, working in partnership with the Health Research Authority
0.47MB

Rob Hemmings - Overview: role of real-world data in drug development and for post-authorisation evidence generation
0.91MB

Samantha Roberts - Overview: role of real-world data in drug development and for post-authorisation evidence generation
0.37MB

Sarah Blagden - Researcher’s perspective: benefits of complex clinical trial designs
1.63MB

Tony Soteriou - NIHR perspective: maintaining UK competitiveness
1.22MB